New Results
Epithelial-mesenchymal plasticity determines estrogen receptor positive (ER+) breast cancer dormancy and reacquisition of an epithelial state drives awakening
Patrick Aouad, Yueyun Zhang, Céline Stibolt, Sendurai A. Mani, George Sflomos, View ORCID ProfileCathrin Brisken
doi: https://doi.org/10.1101/2021.07.22.453458
Patrick Aouad
1ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
Yueyun Zhang
1ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
Céline Stibolt
1ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
Sendurai A. Mani
2Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Texas 77030
George Sflomos
1ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
Cathrin Brisken
1ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
3The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK

Article usage
Posted July 26, 2021.
Epithelial-mesenchymal plasticity determines estrogen receptor positive (ER+) breast cancer dormancy and reacquisition of an epithelial state drives awakening
Patrick Aouad, Yueyun Zhang, Céline Stibolt, Sendurai A. Mani, George Sflomos, Cathrin Brisken
bioRxiv 2021.07.22.453458; doi: https://doi.org/10.1101/2021.07.22.453458
Epithelial-mesenchymal plasticity determines estrogen receptor positive (ER+) breast cancer dormancy and reacquisition of an epithelial state drives awakening
Patrick Aouad, Yueyun Zhang, Céline Stibolt, Sendurai A. Mani, George Sflomos, Cathrin Brisken
bioRxiv 2021.07.22.453458; doi: https://doi.org/10.1101/2021.07.22.453458
Subject Area
Subject Areas
- Biochemistry (7520)
- Bioengineering (5479)
- Bioinformatics (20677)
- Biophysics (10258)
- Cancer Biology (7931)
- Cell Biology (11583)
- Clinical Trials (138)
- Developmental Biology (6563)
- Ecology (10136)
- Epidemiology (2065)
- Evolutionary Biology (13540)
- Genetics (9498)
- Genomics (12788)
- Immunology (7872)
- Microbiology (19451)
- Molecular Biology (7614)
- Neuroscience (41875)
- Paleontology (306)
- Pathology (1252)
- Pharmacology and Toxicology (2179)
- Physiology (3249)
- Plant Biology (7007)
- Synthetic Biology (1942)
- Systems Biology (5406)
- Zoology (1107)